Murayama T, Itahashi Y, Nomura Y
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
J Neurochem. 1990 Nov;55(5):1631-8. doi: 10.1111/j.1471-4159.1990.tb04949.x.
To identify the involvement of dopamine receptors in the transmembrane signaling of the adenosine receptor-G protein-adenylate cyclase system in the CNS, we examined the effects of pertussis toxin (islet-activating protein, IAP) and apomorphine on A1 adenosine agonist (-)N6-R-[3H]phenylisopropyladenosine ([3H]PIA) and antagonist [3H]xanthine amine congener ([3H]XAC) binding activity and adenylate cyclase activity in cerebral cortex membranes of the rat brain. Specific binding to a single class of sites for [3H]XAC with a dissociation constant (KD) of 6.0 +/- 1.3 nM was observed. The number of maximal binding sites (Bmax) was 1.21 +/- 0.13 pmol/mg protein. Studies of the inhibition of [3H]XAC binding by PIA revealed the presence of two classes of PIA binding states, a high-affinity state (KD = 2.30 +/- 1.16 nM) and a low-affinity state (KD = 1.220 +/- 230 nM). Guanosine 5'-(3-O-thio)triphosphate or IAP treatment reduced the number of the high-affinity state binding sites without altering the KD for PIA. Apomorphine (100 microM) increased the KD value 10-fold and decreased Bmax by approximately 20% for [3H]PIA. The effect of apomorphine on the KD value increase was irreversible and due to a conversion from high-affinity to low-affinity states for PIA. The effect was dose dependent and was mediated via D2 dopamine receptors, since the D2 antagonist sulpiride blocked the phenomenon. The inhibitory effect of PIA on adenylate cyclase activity was abolished by apomorphine treatment. There was no effect of apomorphine on displacement of [3H]quinuclidinyl benzilate (muscarinic ligand) binding by carbachol. These data suggest that A1 adenosine receptor binding and function are selectively modified by D2 dopaminergic agents.
为了确定多巴胺受体在中枢神经系统中腺苷受体 - G蛋白 - 腺苷酸环化酶系统跨膜信号传导中的作用,我们研究了百日咳毒素(胰岛激活蛋白,IAP)和阿扑吗啡对大鼠脑皮质膜中A1腺苷激动剂(-)N6 - R - [3H]苯基异丙基腺苷([3H] PIA)和拮抗剂[3H]黄嘌呤胺同类物([3H] XAC)结合活性以及腺苷酸环化酶活性的影响。观察到与一类[3H] XAC位点的特异性结合,其解离常数(KD)为6.0±1.3 nM。最大结合位点(Bmax)的数量为1.21±0.13 pmol/mg蛋白质。PIA对[3H] XAC结合的抑制研究表明存在两类PIA结合状态,即高亲和力状态(KD = 2.30±1.16 nM)和低亲和力状态(KD = 1.220±230 nM)。鸟苷5'-(3 - O - 硫代)三磷酸或IAP处理减少了高亲和力状态结合位点的数量,而未改变PIA的KD。阿扑吗啡(100μM)使[3H] PIA的KD值增加10倍,并使Bmax降低约20%。阿扑吗啡对KD值增加的影响是不可逆的,并且是由于PIA从高亲和力状态转变为低亲和力状态。该作用是剂量依赖性的,并且是通过D2多巴胺受体介导的,因为D2拮抗剂舒必利阻断了该现象。阿扑吗啡处理消除了PIA对腺苷酸环化酶活性的抑制作用。阿扑吗啡对卡巴胆碱取代[3H]喹核醇基苯甲酸酯(毒蕈碱配体)结合没有影响。这些数据表明A1腺苷受体的结合和功能被D2多巴胺能药物选择性地修饰。